The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man
- PMID: 6861446
- DOI: 10.1042/cs0650143
The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man
Abstract
Adrenaline was infused intravenously in nine normal volunteers to plasma concentrations similar to those found after myocardial infarction. This study was undertaken on three occasions after 5 days' treatment with placebo or the beta-adrenoceptor antagonists, atenolol or timolol. Adrenaline increased the systolic pressure by 11 mmHg, decreased the diastolic pressure by 14 mmHg, and increased the heart rate by 7 beats/min. These changes were prevented by atenolol. However, after timolol the diastolic pressure rose (+19 mmHg) and heart rate fell (-8 beats/min). Adrenaline caused the corrected QT interval (QTc) to lengthen (0.36 +/- 0.02 s to 0.41 +/- 0.06 s). No significant changes were found in the QTc when subjects were pretreated with atenolol or timolol. The serum potassium fell from 4.06 to 3.22 mmol/l after adrenaline. Serum potassium fell to a lesser extent to 3.67 mmol/l after atenolol and actually increased to 4.25 mmol/l after timolol. Adrenaline-mediated hypokalaemia appears to result from the stimulation of a beta 2-adrenoceptor linked to membrane Na+/K+-ATPase causing potassium influx.
Similar articles
-
Epinephrine-induced hypokalemia: the role of beta adrenoceptors.Am J Cardiol. 1986 Apr 25;57(12):23F-27F. doi: 10.1016/0002-9149(86)90884-2. Am J Cardiol. 1986. PMID: 3010693 Clinical Trial.
-
Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.Angiology. 1990 Mar;41(3):175-88. doi: 10.1177/000331979004100302. Angiology. 1990. PMID: 1968731 Clinical Trial.
-
Adrenaline causes hypokalaemia in man by beta 2 adrenoceptor stimulation.Clin Endocrinol (Oxf). 1984 Apr;20(4):409-14. doi: 10.1111/j.1365-2265.1984.tb03436.x. Clin Endocrinol (Oxf). 1984. PMID: 6143631 Clinical Trial.
-
Effects of atenolol and pindolol on the hypokalaemic and cardiovascular responses to adrenaline infusion.Eur J Clin Pharmacol. 1989;37(1):23-7. doi: 10.1007/BF00609418. Eur J Clin Pharmacol. 1989. PMID: 2591459 Clinical Trial.
-
Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.Br J Clin Pharmacol. 1989 May;27(5):553-61. doi: 10.1111/j.1365-2125.1989.tb03417.x. Br J Clin Pharmacol. 1989. PMID: 2569322 Free PMC article. Clinical Trial.
Cited by
-
The effects of beta blockade on dopamine and dobutamine induced hypokalaemia in dogs.Intensive Care Med. 1989;15(7):452-7. doi: 10.1007/BF00255601. Intensive Care Med. 1989. PMID: 2600289
-
Effect of diabetes on serum potassium concentrations in acute coronary syndromes.Heart. 2003 Jan;89(1):31-5. doi: 10.1136/heart.89.1.31. Heart. 2003. PMID: 12482786 Free PMC article.
-
Evaluation of the metabolic responses to inhaled salbutamol in the measurement of beta 2-adrenoceptor blockade.Eur J Clin Pharmacol. 1989;37(3):297-300. doi: 10.1007/BF00679788. Eur J Clin Pharmacol. 1989. PMID: 2575521 Clinical Trial.
-
Modulation of the effects of salbutamol by propranolol and atenolol.Eur J Clin Pharmacol. 1989;36(5):449-53. doi: 10.1007/BF00558068. Eur J Clin Pharmacol. 1989. PMID: 2753063
-
Haemodynamic, metabolic, and lymphocyte beta 2-adrenoceptor changes following chronic beta-adrenoceptor antagonism.Eur J Clin Pharmacol. 1987;32(3):237-43. doi: 10.1007/BF00607569. Eur J Clin Pharmacol. 1987. PMID: 2885202 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical